Showing results (41-50 of 259) with videos related to

Sort By:
Pageof 26
Biomed Research International|December 23, 2014
Clinical outcome of bortezomib retreatment in patients with relapsed or refractory multiple myelomaJae-Sook Ahn, Sung-Hoon Jung, Seung-Shin Lee, et al.
Oncotarget|May 3, 2017
Combination therapy with dendritic cells and lenalidomide is an effective approach to enhance antitumor immunity in a mouse colon cancer modelManh-Cuong Vo, Thanh-Nhan Nguyen-Pham, Hyun-Ju Lee, et al.
Chonnam Medical Journal|January 6, 2016
Predictive Efficacy of Interim Positron Emission Tomography/Computed Tomography (PET/CT) for the Treatment of Aggressive LymphomaDeok-Hwan Yang, Sung-Hoon Jung, Jae-Sook Ahn, et al.
Annals of Hematology|November 19, 2009
Clinical efficacy of a bortezomib, cyclophosphamide, thalidomide, and dexamethasone (Vel-CTD) regimen in patients with relapsed or refractory multiple myeloma: a phase II studyYeo-Kyeoung Kim, Sang-Kyun Sohn, Jae-Hoon Lee, et al.
BMC Cancer|January 16, 2019
Optimal chemo-mobilization for the collection of peripheral blood stem cells in patients with multiple myelomaGa-Young Song, Sung-Hoon Jung, Seo-Yeon Ahn, et al.
Acta Haematologica|December 1, 2006
Pilot remission induction therapy with idarubicin, plus an intensified dose of ara-C and priming with granulocyte colony-stimulating factor for acute myeloid leukemiaJin Ho Baek, Sang Kyun Sohn, Dong Hwan Kim, et al.
Blood Research|July 29, 2020
Frontline therapy for newly diagnosed patients with multiple myelomaSung-Hoon Jung, Jae-Cheol Jo, Ga-Young Song, et al.
Life Sciences|July 24, 2003
Comparison of the gene expression profiles of monocytic versus granulocytic lineages of HL-60 leukemia cell differentiation by DNA microarray analysisJu Han Song, Jong Man Kim, Seung Hyun Kim, et al.
Case Reports in Oncology|April 28, 2012
Successful Treatment of Pure Red Cell Aplasia with Rituximab in Patients after ABO-Compatible Allogeneic Hematopoietic Stem Cell TransplantationSung-Hoon Jung, Jae-Sook Ahn, Deok-Hwan Yang, et al.
Plos One|January 26, 2013
Allelic expression imbalance of JAK2 V617F mutation in BCR-ABL negative myeloproliferative neoplasmsHye-Ran Kim, Hyun-Jung Choi, Yeo-Kyeoung Kim, et al.
Pageof 26